We are live on ! Find out more
URGN icon

UroGen Pharma
URGN

77 hedge funds and large institutions have $140M invested in UroGen Pharma in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 22 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more call options, than puts

Call options by funds: $5K | Put options by funds: $4K

2.69% more ownership

Funds ownership: 63% → 65.68% (+2.7%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 22

16% less funds holding

Funds holding: 92 → 77 (-15)

41% less capital invested

Capital invested by funds: $237M → $140M (-$96.6M)

67% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 21

Holders
77
Holders Change
-15
Holders Change %
-16.3%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
21
Reduced
22
Closed
21
Calls
$5K
Puts
$4K
Net Calls
+$1K
Net Calls Change
-$21K

Top Buyers

Rank Fund Capital Flow
1
HIIFS
Harel Insurance Investments & Financial Services
Israel
+$14.5M
2
GPP
Great Point Partners
Connecticut
+$1.74M
3
Cerity Partners
Cerity Partners
New York
+$1.67M
4
UBS Group
UBS Group
Switzerland
+$653K
5
CBA
Coastal Bridge Advisors
Connecticut
+$522K

Top Sellers

Rank Fund Capital Flow
1
VOYA Investment Management
VOYA Investment Management
Georgia
-$2.5M
2
ZCA
Zeke Capital Advisors
Pennsylvania
-$1.83M
3
HP
HealthInvest Partners
Sweden
-$1.26M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.12M
5
Citadel Advisors
Citadel Advisors
Florida
-$964K
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
51
Deutsche Bank
Germany
$120K +$8.88K +630 +5%
AIG
52
American International Group
New York
$99K -$4.36K -309 -3%
ACM
53
Aquatic Capital Management
Illinois
$61K +$90.4K +6,410 New
Ohio Public Employees Retirement System (OPERS)
54
Ohio Public Employees Retirement System (OPERS)
Ohio
$59K – – –
Citigroup
55
Citigroup
New York
$53K +$30.6K +2,169 +63%
BNP Paribas Financial Markets
56
BNP Paribas Financial Markets
France
$42.7K +$13.2K +934 +26%
Legal & General Group
57
Legal & General Group
United Kingdom
$27K – – –
TRCT
58
Tower Research Capital (TRC)
New York
$21K +$22.6K +1,605 +268%
SIAP
59
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$19K – – –
Russell Investments Group
60
Russell Investments Group
United Kingdom
$18K -$776K -55,035 -97%
AIP
61
Ameritas Investment Partners
Nebraska
$16K – – –
Public Employees Retirement Association of Colorado
62
Public Employees Retirement Association of Colorado
Colorado
$13K – – –
Zurich Cantonal Bank
63
Zurich Cantonal Bank
Switzerland
$12K – – –
JWA
64
JFS Wealth Advisors
Pennsylvania
$10K +$14.1K +1,000 New
First Manhattan
65
First Manhattan
New York
$9K – – –
Macquarie Group
66
Macquarie Group
Australia
$9K – – –
US Bancorp
67
US Bancorp
Minnesota
$6K +$2.95K +209 +53%
SPIA
68
Steward Partners Investment Advisory
New York
$5K – – –
Osaic Holdings
69
Osaic Holdings
Arizona
$5K +$7.05K +500 New
SOW
70
State of Wyoming
Wyoming
$3K -$381 -27 -8%
EI
71
Ellevest Inc
New York
$1K -$169 -12 -7%
CSWM
72
Cassady Schiller Wealth Management
Ohio
$1K +$2.04K +145 New
Simplex Trading
73
Simplex Trading
Illinois
$1K +$2.68K +190 +2,111%
Manulife (Manufacturers Life Insurance)
74
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$113 -$4.65K -330 -3%
VOYA Investment Management
75
VOYA Investment Management
Georgia
– -$2.5M -148,439 Closed
1 2
3
4

URGN Hedge Fund Activity: Q4 2021 in Review

77 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in UroGen Pharma (URGN) for Q4 2021, worth a combined $140M — down 41% from $237M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of URGN and 7 opened new positions — a net loss of 14 holders — while 22 trimmed existing stakes and 21 added.

The largest buyer was Harel Insurance Investments & Financial Services, opening a new position worth an estimated $14.5M. The largest seller was VOYA Investment Management, exiting entirely with an estimated $2.5M sold.

  • 77 institutional investors held UroGen Pharma (URGN) as of Q4 2021, down from 92 in Q3 2021.
  • Funds reported $140M of UroGen Pharma stock for Q4 2021, down 41% quarter-over-quarter.
  • 7 funds opened new UroGen Pharma positions in Q4 2021 and 21 closed out, a net change of -14 holders.
  • The largest UroGen Pharma buyer in Q4 2021 was Harel Insurance Investments & Financial Services, an estimated $14.5M added.
  • The largest UroGen Pharma seller in Q4 2021 was VOYA Investment Management, an estimated $2.5M sold.

Based on aggregated 13F filings for Q4 2021.